You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 42 No. 5, May 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Plasma Cortisol Determination for the Dexamethasone Suppression Test

Comparison of Competitive Protein-Binding and Commercial Radioimmunoassay Methods

James C. Ritchie, MPH; Bernard J. Carroll, MD, PhD; Pamela R. Olton; Vera Shively; Michael Feinberg, MD, PhD

Arch Gen Psychiatry. 1985;42(5):493-497.


Abstract

• Quality control serum samples and postdexamethasone plasma pools were used to compare 16 commercial cortisol radioimmunoassay kits with the competitive protein-binding assay for plasma glucocorticoids that we used to standardize the dexamethasone suppression test (DST). Thirteen radioimmunoassays gave higher criterion values for the DST than those established using the competitive protein-binding assay. The range of radioimmunoassay criterion values was 4.34 to 8.70 µ Possible explanations are given for these findings, and their importance to the clinical utility of the DST are emphasized. Each laboratory should validate its own criterion cortisol value for depression based on local data, including appropriate control groups.



Author Affiliations

From the Department of Psychiatry, Duke University, Durham, NC (Mr Ritchie and Dr Carroll); and the University of Michigan, Mental Health Research Institute, Ann Arbor (Mss Olton and Shively and Dr Feinberg).


Footnotes

Accepted for publication Sept 10, 1984.

Reprint requests to Clinical Psychobiology Laboratory, 172 Sands Bldg, Box 3856, Duke University Medical Center, Durham, NC 27710 (Mr Ritchie).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Low-Dose Dexamethasone Suppression Test: A Reevaluation in Patients with Cushing's Syndrome
Findling et al.
J. Clin. Endocrinol. Metab. 2004;89:1222-1226.
ABSTRACT | FULL TEXT  

Marked Reduction in the Number of Platelet--Tritiated Imipramine Binding Sites in Geriatric Depression
Nemeroff et al.
Arch Gen Psychiatry 1988;45:919-923.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.